CD94 Is Essential for NK Cell-Mediated Resistance to a Lethal Viral Disease

Immunity

Volumn 34, Issue 4, 2011, Pages 579-589

  Fang, Min ^a   Orr, Mark T ^b   Spee, Pieter ^c   Egebjerg, Thomas ^c   Lanier, Lewis L ^b   Sigal, Luis J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ECTROMELIA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONKEYPOX VIRUS; MOUSE; MOUSEPOX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SMALLPOX VIRUS; VIRUS RESISTANCE;

ANIMALS; CELL LINE; CELL MOVEMENT; ECTROMELIA, INFECTIOUS; HUMANS; KILLER CELLS, NATURAL; LYMPH NODES; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D;

EID: 79954568378     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.02.015     Document Type: Article

References (42)

1. Aldrich C.J., DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994, 79:649-658.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
3. Brown M.G., Scalzo A.A. NK gene complex dynamics and selection for NK cell receptors. Semin. Immunol. 2008, 20:361-368.
4. Brownstein D.G., Bhatt P.N., Gras L., Jacoby R.O. Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J. Virol. 1991, 65:1946-1951.
5. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 2001, 194:29-44.
6. Davis R.C., Schadt E.E., Smith D.J., Hsieh E.W., Cervino A.C., van Nas A., Rosales M., Doss S., Meng H., Allayee H., Lusis A.J. A genome-wide set of congenic mouse strains derived from DBA/2J on a C57BL/6J background. Genomics 2005, 86:259-270.
7. DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. J. Immunol. 1997, 158:2183-2191.
8. Delano M.L., Brownstein D.G. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 1995, 69:5875-5877.
9. Elroy-Stein O., Moss B. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc. Natl. Acad. Sci. USA 1990, 87:6743-6747.
10. Fang M., Sigal L.J. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 2005, 175:6829-6836.
11. Fang M., Sigal L.J. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. J. Immunol. 2006, 177:8027-8036.
12. Fang M., Sigal L. Studying NK cell responses to ectromelia virus infections in mice. Methods Mol. Biol. 2010, 612:411-428.
13. Fang M., Lanier L.L., Sigal L.J. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008, 4:e30.
14. Fang M., Roscoe F., Sigal L.J. Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking. J. Exp. Med. 2010, 207:2369-2381.
15. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006, 7:517-523.
16. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
17. Gross E. Update on emerging infections: News from the Centers for Disease Control and prevention. Update: Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Ann. Emerg. Med. 2003, 42:660-662, discussion 662-664.
18. Gumá M., Budt M., Sáez A., Brckalo T., Hengel H., Angulo A., López-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
19. Hooijberg E., Bakker A.Q., Ruizendaal J.J., Spits H. NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells. Blood 2000, 96:459-466.
20. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 2004, 5:516-523.
21. Jacoby R.O., Bhatt P.N., Brownstein D.G. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch. Virol. 1989, 108:49-58.
22. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002, 17:19-29.
23. Kielczewska A., Pyzik M., Sun T., Krmpotic A., Lodoen M.B., Munks M.W., Babic M., Hill A.B., Koszinowski U.H., Jonjic S., et al. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 2009, 206:515-523.
24. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
25. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 2008, 8:259-268.
26. Lanier L.L. Up on the tightrope: Natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495-502.
27. Larkin M. Monkeypox spreads as US public-health system plays catch-up. Lancet Infect. Dis. 2003, 3:461.
28. Lee S.H., Biron C.A. Here today-Not gone tomorrow: Roles for activating receptors in sustaining NK cells during viral infections. Eur. J. Immunol. 2010, 40:923-932.
29. Lu L., Werneck M.B., Cantor H. The immunoregulatory effects of Qa-1. Immunol. Rev. 2006, 212:51-59.
30. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
31. Murata K., Inami M., Hasegawa A., Kubo S., Kimura M., Yamashita M., Hosokawa H., Nagao T., Suzuki K., Hashimoto K., et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int. Immunol. 2003, 15:987-992.
32. Orr M.T., Wu J., Fang M., Sigal L.J., Spee P., Egebjerg T., Dissen E., Fossum S., Phillips J.H., Lanier L.L. Development and function of CD94-deficient natural killer cells. PLoS ONE 2010, 5:e15184.
33. Parker A.K., Parker S., Yokoyama W.M., Corbett J.A., Buller R.M. Induction of natural killer cell responses by ectromelia virus controls infection. J. Virol. 2007, 81:4070-4079.
34. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997, 158:2723-2730.
35. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002, 99:8826-8831.
36. Tscharke D.C., Karupiah G., Zhou J., Palmore T., Irvine K.R., Haeryfar S.M., Williams S., Sidney J., Sette A., Bennink J.R., Yewdell J.W. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 2005, 201:95-104.
37. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 1998, 188:1841-1848.
38. Vance R.E., Jamieson A.M., Raulet D.H. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 1999, 190:1801-1812.
39. Vance R.E., Jamieson A.M., Cado D., Raulet D.H. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc. Natl. Acad. Sci. USA 2002, 99:868-873.
40. Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 2000, 192:1059-1068.
41. Xu R.H., Fang M., Klein-Szanto A., Sigal L.J. Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection. Proc. Natl. Acad. Sci. USA 2007, 104:10992-10997.
42. Yokoyama W.M., Ryan J.C., Hunter J.J., Smith H.R., Stark M., Seaman W.E. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J. Immunol. 1991, 147:3229-3236.